Reference
Holmes Z, et al. Treatment of severe, refractory pyoderma gangrenosum with infliximab, adalimumab and intravenous immunoglobulin. Australasian Journal of Dermatology 64 : 433-435, No. 3, Aug 2023. Available from: URL: http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1440-0960
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1979, 18 (2023). https://doi.org/10.1007/s40278-023-47745-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-47745-9